What Tesa / Ipa / MOTS-c Blend actually is

This advanced blend combines Tesamorelin (the FDA-approved GHRH analogue with documented visceral fat reduction), Ipamorelin (selective ghrelin agonist), and MOTS-c (mitochondrial-encoded peptide). The result is a stack hitting central adiposity, GH/IGF axis, and mitochondrial substrate simultaneously.¹

MOTS-c adds AMPK activation and exercise-mimetic gene programs, which is particularly relevant in patients pursuing metabolic flexibility alongside body-composition changes.² The Tesa/Ipa combination delivers a stronger GH pulse than either compound alone while preserving Tesamorelin’s visceral-fat selectivity.

At Luxbae, Tesa / Ipa / MOTS-c Blend is prescribed and supervised by Dr. Ernst von Schwarz, MD, PhD after a complimentary medical consultation.

Mechanism — GH axis plus mitochondria

Tesamorelin and Ipamorelin together drive a strong pulsatile GH release; MOTS-c overlays AMPK and mitochondrial integrated stress response support.¹

What the research shows

Layered fat reduction. Tesamorelin’s VAT effect plus MOTS-c’s metabolic flexibility — cumulative metabolic remodeling.

Stronger GH pulse. Ipamorelin’s ghrelin arm amplifies Tesamorelin’s GHRH pulse.

Mitochondrial fitness. MOTS-c upregulates AMPK and supports mitochondrial integrated stress response.²

Side effects: Injection-site reactions, peripheral edema, arthralgias, transient flushing, glucose changes.

FDA note: Tesamorelin is FDA-approved for HIV lipodystrophy; the blend is compounded and considered investigational.

Tesa / Ipa / MOTS-c Blend FAQ

Why three compounds?
Each addresses a different axis — GHRH, ghrelin, mitochondrial. Combined effect exceeds single agents.

Better than Tesa alone?
For broader metabolic goals — yes. For visceral fat only, Tesa alone is sufficient.

References

1. Falutz J, Allas S, Blot K, et al. Metabolic effects of GHRH in HIV lipodystrophy. N Engl J Med. 2007;357(23):2359-2370.
2. Lee C, Zeng J, Drew BG, et al. MOTS-c promotes metabolic homeostasis. Cell Metab. 2015;21(3):443-454.
3. Reynolds JC, Lai RW, Woodhead JST, et al. MOTS-c is an exercise-induced regulator. Nat Commun. 2021;12(1):470.